Show simple item record

dc.contributor.authorSineh Sepehr, K
dc.contributor.authorBaradaran, B
dc.contributor.authorMajidi, J
dc.contributor.authorAbdolalizadeh, J
dc.contributor.authorAghebati, L
dc.contributor.authorShahneh, FZ
dc.date.accessioned2018-08-26T09:00:49Z
dc.date.available2018-08-26T09:00:49Z
dc.date.issued2013
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54947
dc.description.abstractPurpose: Monoclonal antibodies are important tools are used in basic research as well as, in diagnosis, imaging and treatment of immunodeficiency diseases, infections and cancers. The purpose of this study was to produce large scale of monoclonal antibody against CD20 in order to diagnostic application in leukemia and lymphomas disorders. Methods: Hybridoma cells that produce monoclonal antibody against human CD20 were administered into the peritoneum of the Balb/c mice which have previously been primed with 0.5 ml Pristane. After twelve days, approximately 7 ml ascetic fluid was harvested from the peritoneum of each mouse. Evaluation of mAb titration was assessed by ELISA method. In the present study, we describe a protocol for large scale production of MAbs. Results: We prepared monoclonal antibodies (mAbs) with high specificity and sensitivity against human CD20 by hybridoma method and characterized them by ELISA. The subclass of antibody was IgG2a and its light chain was kappa. Ascetic fluid was purified by Protein-A Sepharose affinity chromatography and the purified monoclonal antibody was conjugated with FITC and Immunofluorescence was done for confirming the specific binding. Conclusion: The conjugated monoclonal antibody could have application in diagnosis B-cell lymphomas, hairy cell leukemia, B-cell chronic lymphocytic leukemia, and melanoma cancer stem cells. é 2013 by Tabriz University of Medical Sciences.
dc.language.isoEnglish
dc.relation.ispartofAdvanced Pharmaceutical Bulletin
dc.subjectCD20 antibody
dc.subjectfluorescein isothiocyanate
dc.subjectimmunoglobulin G2a antibody
dc.subjectmonoclonal antibody
dc.subjectpristane
dc.subjectprotein A
dc.subjectsepharose
dc.subjectaffinity chromatography
dc.subjectanimal experiment
dc.subjectanimal tissue
dc.subjectantibody production
dc.subjectantibody specificity
dc.subjectantibody titer
dc.subjectantigen binding
dc.subjectarticle
dc.subjectascites fluid
dc.subjectBagg albino mouse
dc.subjectcontrolled study
dc.subjectdrug conjugation
dc.subjectdrug manufacture
dc.subjectdrug purification
dc.subjectenzyme linked immunosorbent assay
dc.subjectfemale
dc.subjecthybridoma cell culture
dc.subjectimmunofluorescence test
dc.subjectin vivo study
dc.subjectlight chain
dc.subjectmouse
dc.subjectnonhuman
dc.subjectperitoneum
dc.subjectsensitivity and specificity
dc.titleMass-production and characterization of anti-CD20 monoclonal antibody in peritoneum of Balb/c mice
dc.typeArticle
dc.citation.volume3
dc.citation.issue1
dc.citation.spage109
dc.citation.epage113
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.5681/apb.2013.018


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record